ATE401402T1 - Mit syndekan interagierende proteine und deren verwendung - Google Patents

Mit syndekan interagierende proteine und deren verwendung

Info

Publication number: ATE401402T1
Authority: AT; Austria
Prior art keywords: syntenin; syndecan; tyrosine residues; protein; present
Prior art date: 1997-04-25

Application number

AT98924211T

Other languages

English (en)

Inventor

Jan Grootjans

Pascale Zimmermann

Guido David

Original Assignee

Vlaams Interuniv Inst Biotech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-25

Filing date

1998-04-22

Publication date

2008-08-15

1998-04-22 Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech

2008-08-15 Application granted granted Critical

2008-08-15 Publication of ATE401402T1 publication Critical patent/ATE401402T1/de

Links

102000004169 proteins and genes Human genes 0.000 title abstract 4
108090000623 proteins and genes Proteins 0.000 title abstract 4
102100037219 Syntenin-1 Human genes 0.000 abstract 3
108010083130 Syntenins Proteins 0.000 abstract 3
102000019361 Syndecan Human genes 0.000 abstract 2
108050006774 Syndecan Proteins 0.000 abstract 2
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 abstract 2
208000024827 Alzheimer disease Diseases 0.000 abstract 1
125000001433 C-terminal amino-acid group Chemical group 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
102000000470 PDZ domains Human genes 0.000 abstract 1
108050008994 PDZ domains Proteins 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
230000001086 cytosolic effect Effects 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
230000003993 interaction Effects 0.000 abstract 1
230000002452 interceptive effect Effects 0.000 abstract 1
230000036210 malignancy Effects 0.000 abstract 1
DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT98924211T 1997-04-25 1998-04-22 Mit syndekan interagierende proteine und deren verwendung ATE401402T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97201233		1997-04-25

Publications (1)

Publication Number	Publication Date
ATE401402T1 true ATE401402T1 (de)	2008-08-15

Family

ID=8228252

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98924211T ATE401402T1 (de)	1997-04-25	1998-04-22	Mit syndekan interagierende proteine und deren verwendung

Country Status (7)

Country	Link
US (1)	US6368811B1 (de)
EP (1)	EP1012277B1 (de)
AT (1)	ATE401402T1 (de)
AU (1)	AU7649098A (de)
CA (1)	CA2288376C (de)
DE (1)	DE69839733D1 (de)
WO (1)	WO1998049290A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6866993B1 (en) *	1999-03-23	2005-03-15	Millennium Pharmaceuticals, Inc.	MDA-9 and uses thereof
IL133318A0 (en) *	1999-12-05	2001-04-30	Yeda Res & Dev	Proteoglycans and pharmaceutical compositions comprising them
WO2004026331A1 (en) *	2002-09-17	2004-04-01	Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw	Peptides inhibiting specific cleaving activities of presenilins
US7209786B2 (en) *	2004-06-10	2007-04-24	Cardiac Pacemakers, Inc.	Method and apparatus for optimization of cardiac resynchronization therapy using heart sounds
WO2009105624A2 (en) *	2008-02-21	2009-08-27	Massachusetts Institute Of Technology	Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity
JP6215205B2 (ja) *	2012-07-23	2017-10-18	公益財団法人東京都医学総合研究所	スパイン形成異常を抑制するための医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2141600A1 (en) *	1992-08-03	1994-02-17	Richard U. Margolis	Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan
US6071696A (en) *	1996-12-30	2000-06-06	The Trustees Of Columbia University In The City Of New York	Method of producing a temporally spaced subtracted (TSS) CDNA library and use thereof to monitor differentiation

1998
- 1998-04-22 EP EP98924211A patent/EP1012277B1/de not_active Expired - Lifetime
- 1998-04-22 WO PCT/EP1998/002464 patent/WO1998049290A2/en not_active Ceased
- 1998-04-22 AT AT98924211T patent/ATE401402T1/de not_active IP Right Cessation
- 1998-04-22 AU AU76490/98A patent/AU7649098A/en not_active Abandoned
- 1998-04-22 CA CA002288376A patent/CA2288376C/en not_active Expired - Fee Related
- 1998-04-22 DE DE69839733T patent/DE69839733D1/de not_active Expired - Fee Related
1999
- 1999-10-25 US US09/427,261 patent/US6368811B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6368811B1 (en)	2002-04-09
CA2288376A1 (en)	1998-11-05
EP1012277B1 (de)	2008-07-16
EP1012277A2 (de)	2000-06-28
WO1998049290A2 (en)	1998-11-05
AU7649098A (en)	1998-11-24
WO1998049290A3 (en)	1999-02-18
DE69839733D1 (de)	2008-08-28
CA2288376C (en)	2003-10-14

Similar Documents

Publication	Publication Date	Title
Maddox et al.	1989	Connective tissue microfibrils: isolation and characterization of three large pepsin-resistant domains of fibrillin
Poser et al.	1980	Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue.
Neame et al.	1989	The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage
Kao et al.	1994	A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response
PT93910A (pt)	1991-01-08	Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
EP0662827A4 (de)	1997-12-03	Therapeutische und diagnostische verfahren und zusammensetzungen auf der basis von notch-proteinen und nukleinsäuren.
RU93045577A (ru)	1996-02-27	Слитные полипептиды
RU99107759A (ru)	2001-05-27	Применение антагонистов лептина для лечения резистентности к инсулину при диабете ii типа
DE69836131D1 (de)	2006-11-23	Neue menschliche delta3-zusammensetzung und deren therapeutische und diagnostische verwendungen
US20080081784A1 (en)	2008-04-03	Paralytic Peptide For Use In Neuromuscular Therapy
Hale et al.	1991	Carboxyl-terminal proteolytic processing of matrix Gla protein.
Davis et al.	1991	Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and β2-microglobulin
Bornstein et al.	1970	The comparative biochemistry of collagen: The structure of rabbit skin collagen and its relevance to immunochemical studies of collagen
PT877803E (pt)	2005-11-30	Receptor da proteina ob e composicoes e metodos afins
ECSP055849A (es)	2005-09-20	Anticuerpo ("11c7") anti-nogo a y su uso farmacéutico
ATE401402T1 (de)	2008-08-15	Mit syndekan interagierende proteine und deren verwendung
ATE408685T1 (de)	2008-10-15	Antimikrobielle peptide, abstammend von ubiquicidin
Mayne et al.	1983	The use of monoclonal antibodies to fragments of chicken type IV collagen in structural and localization studies.
DE69736158D1 (de)	2006-08-03	Glutamine: Fructose-6-Phosphat Amidotransferase (GFAT), ihre Herstellung und Verwendung
Qian et al.	1984	Separation and characterization of two polypeptide chains from the 7S cross-linking domain of basement-membrane (type IV) collagen
US7485622B2 (en)	2009-02-03	Paralytic peptide for use in neuromuscular therapy
GEP20043386B (en)	2004-02-10	β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
ATE294816T1 (de)	2005-05-15	Neue, physiologisch aktive peptide und ihre verwendung.
ATE290088T1 (de)	2005-03-15	Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
AU2676399A (en)	1999-08-30	Novel cystine knot protein and materials and methods for making it

Legal Events

Date	Code	Title	Description
2009-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties